HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Ogino Selected Research

NMS60

6/2006Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Ogino Research Topics

Disease

16Neoplasms (Cancer)
07/2021 - 12/2004
6Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 12/2004
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 10/2015
3Lymphoma (Lymphomas)
03/2016 - 07/2005
2Ewing Sarcoma (Sarcoma, Ewing)
01/2021 - 11/2020
2Ependymoma
03/2016 - 03/2016
2Brain Neoplasms (Brain Tumor)
11/2008 - 06/2006
1Interstitial Lung Diseases (Interstitial Lung Disease)
03/2022
1Lymphatic Metastasis
01/2021
1Infections
01/2020
1Sepsis (Septicemia)
01/2020
1Endometrial Stromal Sarcoma
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Jaundice (Icterus)
01/2020
1Squamous Cell Carcinoma of Head and Neck
10/2019
1Pain (Aches)
02/2018
1Meningioma (Meningiomas)
12/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2016
1Hypopharyngeal Neoplasms
01/2016
1Carcinoma (Carcinomatosis)
01/2016
1Obstructive Jaundice (Cholestatic Jaundice)
10/2015
1Hemoptysis
09/2013
1Air Embolism (Gas Embolism)
09/2013
1Pneumothorax
09/2013
1Hemothorax
09/2013
1Organizing Pneumonia
08/2012
1Multiple Organ Failure (MODS)
06/2012
1Hemorrhage
06/2012
1Proctitis
06/2012
1Septic Shock (Toxic Shock Syndrome)
06/2012
1Hematoma
09/2009
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
09/2009
1False Aneurysm (Pseudoaneurysm)
09/2009
1Mycoplasma Pneumonia
05/2009
1Acute Necrotizing Pancreatitis
05/2009
1Pancreatitis
05/2009
1Atrophy
11/2008
1Dementia (Dementias)
11/2008
1Mesenteric Ischemia
08/2008
1Thymoma (Thymic Carcinoma)
01/2008
1Lung Neoplasms (Lung Cancer)
01/2007
1Radiation Pneumonitis
01/2007
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2005
1Germinoma
07/2005
1Hypoxia (Hypoxemia)
12/2004

Drug/Important Bio-Agent (IBA)

3Protons (Proton)IBA
10/2019 - 09/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2004
1HydrogelsIBA
09/2021
1Testosterone (Sustanon)FDA Link
05/2021
1Prostaglandins AIBA
11/2020
1Polyglycolic Acid (Polyglycolide)IBA
11/2020
1pazopanibFDA Link
01/2020
1Fetal Proteins (Fetoprotein)IBA
03/2019
1acarboxyprothrombin (PIVKA)IBA
03/2019
1Proteins (Proteins, Gene)FDA Link
03/2019
1Vitamin KFDA Link
03/2019
1Biological ProductsIBA
01/2018
1GoldIBA
03/2016
1SteroidsIBA
06/2012
1Suppositories (Vaginal Suppositories)IBA
06/2012
1Gabexate (Foy)IBA
05/2009
1Protease Inhibitors (Protease Inhibitor)IBA
05/2009
1Meropenem (Merrem)FDA LinkGeneric
05/2009
1Methotrexate (Mexate)FDA LinkGeneric
08/2008
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2008
1salicylhydroxamic acid (SHAM)IBA
03/2008
1NMS60IBA
06/2006
1Contrast MediaIBA
06/2006
1Radiation-Sensitizing AgentsIBA
12/2005
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
07/2005
1ProdrugsIBA
12/2004
1Tirapazamine (SR 4233)IBA
12/2004

Therapy/Procedure

18Proton Therapy
03/2022 - 10/2015
14Radiotherapy
03/2019 - 12/2004
4Therapeutics
01/2021 - 05/2009
4Drug Therapy (Chemotherapy)
01/2020 - 01/2006
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2019 - 09/2016
2Aftercare (After-Treatment)
03/2019 - 08/2008
2Punctures
02/2018 - 09/2009
2Re-Irradiation
03/2016 - 03/2016
1Radiofrequency Ablation
01/2021
1Conformal Radiotherapy
09/2016
1Induction Chemotherapy
01/2016
1Chest Tubes (Chest Tube)
09/2013
1Catheters
10/2012
1Enema (Enemas)
06/2012
1Intra-Arterial Infusions
05/2009
1Particle Accelerators
02/2006